Meihua International Medical Technologies Facilitates World's Second* 5G Remote Robot-Assisted Lobectomy

Core Insights - Meihua International Medical Technologies Co., Ltd. announced the successful support of the world's second 5G remote robot-assisted lobectomy, performed on July 15, 2024, at Yangzhou University Affiliated Hospital [1][2][3] - The operation was executed seamlessly in one hour, demonstrating the effectiveness of 5G technology and robotic surgical systems [2] - The company aims to enhance healthcare outcomes and address disparities in medical resource distribution across China through innovations in robotic-assisted surgery [2] Company Overview - Meihua is a manufacturer and provider of Class I, II, and III disposable medical devices, with over 30 years of experience serving hospitals and medical institutions [4] - The company has received international "CE" certification and ISO 13485 system certification, and has registered over 20 Class I products with the FDA [4] - Meihua offers a wide range of products, including surgical kits, medical catheters, and electronic pumps, with over 1,000 types available for domestic sales and more than 120 products exported to over 30 countries [4] Technological Advancements - The NT-2000 surgical path analysis system is designed for real-time monitoring and guidance, improving surgical accuracy and success rates [2] - The company is developing robotic-assisted surgery systems in collaboration with the Hope City Medical Park in Hainan province, with project completion expected in the fall of 2025 [2]